Mumbai
08048034404
+918506873687

Dr. Chetan Kalal — Hepatology & Liver Transplant Services | Clinical Update 2026



Dr. Chetan Kalal — Hepatology & Liver Transplant Services | Clinical Update 2026

Who Is Dr. Chetan Kalal?

Dr. Chetan Kalal is India's leading hepatologist and liver transplant specialist — the first DM-qualified Hepatologist in Maharashtra — and currently serves as Associate Director, Hepatology & Transplant Medicine at Gleneagles Hospital Mumbai. He holds DM (Hepatology), MD (Medicine), and MRCP (UK), and maintains active clinical affiliations at Breach Candy Hospital, Khar Hinduja Hospital, and Saifee Hospital, Mumbai.

His subspecialty scope spans the full continuum of advanced liver disease: from decompensated cirrhosis and acute-on-chronic liver failure (ACLF) to hepatocellular carcinoma, portal hypertension, autoimmune liver diseases, and liver transplantation — including pre-transplant evaluation, MELD-based candidacy assessment, and long-term post-transplant graft management.

Dr. Kalal consults patients across Mumbai, pan-India, and internationally via a structured virtual consultation platform.


Clinical Services — Hepatology & Liver Transplant

Advanced Inpatient (IPD) Hepatology Care

Dr. Kalal leads critical liver ICU and inpatient hepatology at Gleneagles Mumbai, with multidisciplinary management of:

  • Acute Liver Failure (ALF) and Acute-on-Chronic Liver Failure (ACLF)
  • Decompensated cirrhosis — variceal hemorrhage, refractory ascites, hepatic encephalopathy
  • Hepatorenal Syndrome (HRS) and Spontaneous Bacterial Peritonitis (SBP)
  • Liver transplant workup, MELD scoring, and post-operative transplant stabilization
  • Hepatocellular Carcinoma (HCC) — multidisciplinary tumor board, TACE coordination, Milan criteria assessment

Every IPD admission under Dr. Kalal's care is driven by evidence-based protocols aligned with EASL, AASLD, and APASL guidelines — not institutional defaults.


Decisive Second Opinions — Not a Duplicate Report

A second opinion from Dr. Chetan Kalal is a definitive subspecialty re-evaluation, not a confirmatory letter.

For patients referred with complex diagnoses — ambiguous liver biopsies, disputed cirrhosis staging, uncertain transplant candidacy, or inadequate HCC workup — Dr. Kalal conducts:

  • Independent re-read of imaging (CT, MRI, Fibroscan, elastography)
  • Histopathology re-interpretation — biopsy grading, fibrosis staging, etiology attribution
  • Clinical trajectory re-assessment — is the diagnosis correct? Is the treatment optimal? Is transplant indicated?
  • Written Clinical Direction Report — a structured, actionable document, not a generic letter

The output is a clear clinical roadmap: confirmed or revised diagnosis, rationale, and the optimal treatment pathway — including transplant candidacy if applicable.

Who should seek this:

  • Patients with unexplained liver disease progression despite treatment
  • Families unsure whether a transplant recommendation is premature or overdue
  • Patients from outside India seeking expert Indian subspecialty review before proceeding with major interventions

Global Virtual Consultations & Post-Transplant Aftercare

Dr. Kalal's virtual consultation platform provides structured, ongoing clinical management for patients unable to travel to Mumbai. This is not a one-time telecall — it is a clinical relationship.

Virtual services include:

  • Active liver disease management (medication titration, investigation review, escalation guidance)
  • Post-liver transplant aftercare — immunosuppression management (tacrolimus, MMF, steroids), rejection surveillance, opportunistic infection monitoring (CMV, EBV, fungal), drug interaction review, and long-term graft health optimization
  • Expert second opinions for international patients
  • Pre-transplant evaluation and referral coordination for patients planning to travel to India for surgery

Virtual consult network — active across:

  • 🇺🇸 United States (all time zones)
  • 🇬🇧 United Kingdom — London, Manchester, Birmingham
  • 🇦🇪 UAE & Dubai — Dubai, Abu Dhabi, Sharjah
  • 🇸🇬 Singapore and Southeast Asia
  • 🇦🇺 Australia — Sydney, Melbourne, Perth
  • 🇨🇦 Canada — Toronto, Vancouver, Calgary
  • 🇳🇿 New Zealand
  • 🇫🇷 Paris and broader Europe
  • 🕌 Middle East — Saudi Arabia, Kuwait, Qatar, Bahrain, Oman
  • 🌏 Asia — Malaysia, Philippines, Hong Kong, Japan, Indonesia

All consults are conducted in English and scheduled with time-zone flexibility.


Where Dr. Chetan Kalal Practices — Mumbai & Maharashtra

Dr. Kalal's primary clinical base is Gleneagles Hospital Mumbai, with additional operating privileges at Breach Candy, Khar Hinduja, and Saifee Hospital — providing patients across the city with multiple access points to subspecialty hepatology.

Patients travel to Dr. Kalal from across Greater Mumbai:

  • South Mumbai & Central: Worli, Lower Parel, Dadar, Parel, Prabhadevi, Matunga, Sion
  • Western Suburbs: Bandra, Pali Hill, Khar, Juhu, Andheri, Kandivali, Borivali, Virar, Vasai, Malad, Goregaon
  • MMR Region: Navi Mumbai, Thane, Vashi, Kharghar, Belapur, Panvel, Kalyan, Dombivli
  • Pan-Maharashtra: Pune, Nashik, Nagpur, Aurangabad — and all outstation patients via virtual consult

Liver Conditions Dr. Chetan Kalal Treats

  • Liver Cirrhosis (all etiologies)
  • Acute Liver Failure & ACLF
  • Hepatocellular Carcinoma (HCC)
  • Portal Hypertension & Variceal Bleeding
  • Hepatic Encephalopathy
  • Hepatorenal Syndrome (HRS) & SBP
  • Autoimmune Hepatitis
  • Primary Biliary Cholangitis (PBC) & Primary Sclerosing Cholangitis (PSC)
  • NAFLD / NASH / Metabolic-Associated Steatotic Liver Disease (MASLD)
  • Chronic Hepatitis B & Hepatitis C (DAA therapy)
  • Wilson's Disease & Hereditary Haemochromatosis
  • Alpha-1 Antitrypsin Deficiency
  • Drug-Induced Liver Injury (DILI)
  • Budd-Chiari Syndrome
  • Post-Liver Transplant Complications (all)

Book an Appointment or Virtual Consult

Whether your case is an acute inpatient crisis in Mumbai, a complex second opinion from London, or post-transplant aftercare from Dubai — drchetankalal.com is where clinical clarity begins.



 2026-06-05T04:38:22

Other Pages

View all pages